KLI Colloquia are invited research talks of about an hour followed by 30 min discussion. The talks are held in English, open to the public, and offered in hybrid format.
Join via Zoom:
https://us02web.zoom.us/j/5881861923?omn=85945744831
Meeting ID: 588 186 1923
Spring-Summer 2026 KLI Colloquium Series
12 March 2026 (Thurs) 3-4:30 PM CET
What Is Biological Modality, and What Has It Got to Do With Psychology?
Carrie Figdor (University of Iowa)
26 March 2026 (Thurs) 3-4:30 PM CET
The Science of an Evolutionary Transition in Humans
Tim Waring (University of Maine)
9 April 2026 (Thurs) 3-4:30 PM CET
Hierarchies and Power in Primatology and Their Populist Appropriation
Rebekka Hufendiek (Ulm University)
16 April 2026 (Thurs) 3-4:30 PM CET
A Metaphysics for Dialectical Biology
Denis Walsh (University of Toronto)
30 April 2026 (Thurs) 3-4:30 PM CET
What's in a Trait? Reconceptualizing Neurodevelopmental Timing by Seizing Insights From Philosophy
Isabella Sarto-Jackson (KLI)
7 May 2026 (Thurs) 3-4:30 PM CET
The Evolutionary Trajectory of Human Hippocampal-Cortical Interactions
Daniel Reznik (Max Planck Society)
21 May 2026 (Thurs) 3-4:30 PM CET
Why Directionality Emerged in Multicellular Differentiation
Somya Mani (KLI)
28 May 2026 (Thurs) 3-4:30 PM CET
The Interplay of Tissue Mechanics and Gene Regulatory Networks in the Evolution of Morphogenesis
James DiFrisco (Francis Crick Institute)
11 June 2026 (Thurs) 3-4:30 PM CET
Brave Genomes: Genome Plasticity in the Face of Environmental Challenge
Silvia Bulgheresi (University of Vienna)
25 June 2026 (Thurs) 3-4:30 PM CET
Anne LeMaitre (KLI)
KLI Colloquia 2014 – 2026
Event Details
Topic description / abstract:
The Emerging Infectious Disease (EID) crisis has been a global health security challenge for decades, with COVID-19 serving as only the latest example of our inability to prevent outbreaks. In lack of implementing novel evolutionary knowledge explaining the process of emergence, our main focus remains preparing for the inevitable. The Stockholm paradigm (SP) is an alternative evolutionary framework that suggests host changes leading to EID can be predicted because preexisting genetic capacities for colonizing new hosts are highly specific and phylogenetically conservative. The DAMA (Document, Assess, Monitor, Act) protocol is a policy extension of the SP that can both prevent and mitigate EID by enhancing traditional efforts through adding early warning signs and predicting transmission dynamics.
In this talk, I show the importance of establishing efficient communication channels between various stakeholders affected by EIDs. I describe implementation strategies of preventive interventions on global, regional and local scales, and provide guidelines for using such strategies in relevant policy environments of human, livestock and crop diseases.
Biographical note:
Orsolya Rita Bajer-Molnár Ph.D. is an evolutionary biologist, with a passion for both research and education. She received her Master’s diploma from Eötvös Loránd University in Evolutionary biology, Ecology and Systematics. Five years later she completed her Ph.D in Behavioural ecology and Evolutionary biology. She then won a postdoctoral scholarship at Dartmouth College, NH, after which she continued research at UFRN in Brazil. Upon returning, she turned towards the evolutionary dynamics of emerging infectious diseases, which she is currently working on in collaboration with the University of Nebraska (USA) and Centre for Ecology Research (Hungary). She has been a senior fellow at the Konrad Lorenz Institute for Evolution and Cognition Research before working at the Medical University of Vienna.
Throughout her research, she had always been interested in science communication. Overseas she organized networking events, conferences and outreach programmes, and taught graduate and undergraduate students. She took an active role in science communication, and after numerous appearances she just recently gave a TedX talk. Her aim is to increase the visibility of research, and thus facilitate a combined effort to prevent the emerging infectious diseases.

